Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_1

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

3(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(1)

Other(1)

Detailed Status

Completed2

Terminated1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 1

Trials by Phase

Phase 13 (100.0%)

Trials by Status

completed250%

terminated125%

unknown125%

Recent Activity

0 active trials

Showing 4 of 4

terminatedphase_1

A Study of Orally Administered Pimodivir in Adult Participants With Renal Impairment

NCT03947814

completedphase_1

A Study of Orally Administered Pimodivir in Adult Participants With Hepatic Impairment

NCT03816631

unknown

Pre-Approval Access to Pimodivir for the Treatment of Patients With H7N9 Influenza A Infection

NCT03834376

completedphase_1

A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults

NCT03768609

Clinical Trials (4)

Showing 4 of 4 trials

NCT03947814Phase 1

A Study of Orally Administered Pimodivir in Adult Participants With Renal Impairment

Terminated

NCT03816631Phase 1

A Study of Orally Administered Pimodivir in Adult Participants With Hepatic Impairment

Completed

NCT03834376

Pre-Approval Access to Pimodivir for the Treatment of Patients With H7N9 Influenza A Infection

Unknown

NCT03768609Phase 1

A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4